Acidophil, LLC is an innovation partnership whose goal is to create and develop technological solutions to areas of high unmet need. Acidophil’s eponymous founders are Nobel Prize winner Sydney Brenner MD, PhD, and Philip Goelet PhD. Acidophil’s team identifies unmet needs, develops or in-licenses enabling intellectual properties, recruits relevant experts, establishes proof of principle, develops commercial plans and participates in bringing its projects to completion through partnering with either corporations or venture capitalists. Current areas of interest include: The application of biotechnology to the therapy and diagnosis of cancer, cardiovascular disease, and disorders of the central nervous system. The application of biotechnology to renewable chemistry and environmental remediation.
Focus Areas
Notable Investments
